Validation of the EUTOS long-term survival score in a recent independent cohort of "real world" CML patients

Leukemia. 2018 Oct;32(10):2299-2303. doi: 10.1038/s41375-018-0136-7. Epub 2018 Apr 19.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cohort Studies
  • Female
  • Humans
  • Imatinib Mesylate / therapeutic use
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality*
  • Male
  • Middle Aged
  • Young Adult

Substances

  • Imatinib Mesylate